Controversial US-backed vaccine trial in African newborns halted

NewsJaws News FeedSource-attributed news briefs

Published 21 Oct 2026, 18:18 BST1 min read

Save for later

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”

Read the original report at The Guardian.

Read in depth: Politics

An Oregon Army National Guard CH-47 Chinook helicopter demonstrates aerial firefighting with a water bucket.

Politics

UK plans military aircraft support for wildfires ahead of first resilience summit

Fire services across the UK are set to be able to request RAF aircraft for difficult wildfires, alongside plans for specialist protective equipment and an AI unit.

22 Oct 20263 min read

Politics

Full details of Burnham’s water overhaul may wait until 2027 spending review

A broad plan for England’s water sector is expected in December, but officials are still working through how greater public control would operate and what it might cost.

21 Oct 20263 min read

Sources and context

The Guardian

Source headline and summary supplied via NewsData.io. First collected by NewsJaws on 2026-10-22. This is an automated news brief, not original NewsJaws reporting. Dates reflect the source publication. Feed delays may apply.